{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T12:45:06Z","timestamp":1749127506874},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11010-014-2325-7","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T08:02:58Z","timestamp":1420704178000},"page":"181-191","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spleen-specific isoforms of Pax5 and Ataxin-7 as potential proteomic markers of lymphoma-affected spleen"],"prefix":"10.1007","volume":"402","author":[{"given":"Brij","family":"Bharti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnikant","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"key":"2325_CR1","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1600-6143.2010.03067.x","volume":"10","author":"B Kaplan","year":"2010","unstructured":"Kaplan B, Jie T, Diana R, Renz J, Whinery A, Stubbs N, Bracamonte E, Spier C, Schubart P, Rilo H, Gruessner R (2010) Histopathology and immunophenotype of the spleen during acute antibody-mediated rejection. Am J Transpl 10:1316\u20131320","journal-title":"Am J Transpl"},{"key":"2325_CR2","first-page":"272","volume":"50","author":"A Shanker","year":"2003","unstructured":"Shanker A, Singh SM (2003) Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract. Neoplasma 50:272\u2013279","journal-title":"Neoplasma"},{"key":"2325_CR3","first-page":"47","volume":"155","author":"JC Yang","year":"1991","unstructured":"Yang JC, Rickman LS, Bosser SK (1991) The clinical diagnosis of splenomegaly. West J Med 155:47\u201352","journal-title":"West J Med"},{"key":"2325_CR4","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1172\/JCI41717","volume":"120","author":"S Gardenghi","year":"2010","unstructured":"Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S (2010) Hepcidin as a therapeutic tool to limit iron overload and improve anemia in \u03b2-thalassemic mice. J Clin Invest 120:4466\u20134477","journal-title":"J Clin Invest"},{"key":"2325_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1751-553X.2007.00915.x","volume":"30","author":"F Wandroo","year":"2008","unstructured":"Wandroo F, Bell A, Darbyshire P, Pratt G, Stankovic T, Gordon J, Lawson S, Moss P (2008) ZAP-70 is highly expresses in most cases of childhood pre-B cell acute lymphoblastic leukemia. Int J Lab Hematol 30:149\u2013157","journal-title":"Int J Lab Hematol"},{"key":"2325_CR6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/10428194.2013.848983","volume":"55","author":"A Butrym","year":"2014","unstructured":"Butrym A, Prochorec-Sobieszek M, Dzietczenia J, Mazur G (2014) Unclassified small B-cell lymphoma with marked plasmacytic differentiation and Mott cell formation. Leuk & Lymphoma 55:1681\u20131683","journal-title":"Leuk & Lymphoma"},{"key":"2325_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nri1633","volume":"5","author":"P Matthias","year":"2005","unstructured":"Matthias P, Rolink AG (2005) Transcriptional networks in developing and mature B cells. Nat Rev Immunol 5:497\u2013508","journal-title":"Nat Rev Immunol"},{"key":"2325_CR8","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2006-12-062265","volume":"111","author":"L Chen","year":"2008","unstructured":"Chen L, Huynth L, Apgar J, TangL, Rassenti L, Weiss A (2008) Zap-70 enhance IgM signaling independent of its kinase activity in chronic lymphocytic leukemia. Blood 111:2685\u20132692","journal-title":"Blood"},{"key":"2325_CR9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.bbamcr.2011.08.003","volume":"1813","author":"B Bharti","year":"2011","unstructured":"Bharti B, Mishra R (2011) Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton\u2019s lymphoma. Biochim Biophys Acta- MCR 1813:2071\u20132078","journal-title":"Biochim Biophys Acta- MCR"},{"key":"2325_CR10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during assembly of head of bacteriophage-T4. Nature 227:680","journal-title":"Nature"},{"key":"2325_CR11","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"6","author":"A Shevchenko","year":"2006","unstructured":"Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006) In-gel digestion for mass spectrophotometric characterization of proteins and proteomes. Nat Protoc 6:2856\u20132860","journal-title":"Nat Protoc"},{"key":"2325_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1080\/01926230600865523","volume":"34","author":"SA Elmore","year":"2006","unstructured":"Elmore SA (2006) Enhanced histopathology of the spleen. Toxicol Pathol 34:648\u2013655","journal-title":"Toxicol Pathol"},{"key":"2325_CR13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0308-2261(21)00399-4","volume":"12","author":"BE Christensen","year":"1983","unstructured":"Christensen BE, Jonsson V, Videbaek A (1983) The spleen in lymphoproliferative disorders. Clin Haematol 12:517\u2013533","journal-title":"Clin Haematol"},{"key":"2325_CR14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.amjsurg.2004.01.016","volume":"187","author":"L Smith","year":"2004","unstructured":"Smith L, Luna G, Merg AR, McNevin MS, Moore MR, Bax TW (2004) Laparoscopic splenectomy for treatment of splenomegaly. Am J Surg 187:618\u2013620","journal-title":"Am J Surg"},{"key":"2325_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-014-0042-3","volume":"15","author":"HB Chu","year":"2014","unstructured":"Chu HB, Zhang TG, Zhao JH, Jian FG, Xu YB, Wang T, Wang M, Tang JY, Sun HJ, Guo WJ, Zhu XJ (2014) Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhosis patients. BMC Immunol 15:42\u201349","journal-title":"BMC Immunol"},{"key":"2325_CR16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/modpathol.3800831","volume":"20","author":"KC Jensen","year":"2007","unstructured":"Jensen KC, Higgins JPT, Montgomery K, Kaygusuz G, Rijn MVD, Natkunam Y (2007) The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. Mod Pathol 20:871\u2013877","journal-title":"Mod Pathol"},{"key":"2325_CR17","doi-asserted-by":"crossref","first-page":"42565","DOI":"10.1074\/jbc.M106536200","volume":"276","author":"M Lowen","year":"2001","unstructured":"Lowen M, Scott G, Zwollo P (2001) Functional analyses of two alternative isoforms of the transcription factor Pax-5. J Biol Chem 276:42565\u201342574","journal-title":"J Biol Chem"},{"key":"2325_CR18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/j.1460-2075.1996.tb00548.x","volume":"15","author":"P Dorfler","year":"1996","unstructured":"Dorfler P, Busslinger M (1996) C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J 15:1971\u20131982","journal-title":"EMBO J"},{"key":"2325_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1532\/IJH97.06148","volume":"85","author":"M Kimura","year":"2007","unstructured":"Kimura M, Yamaguchi M, Nakamura S, Imai H, Ueno S, Ogawa S, Miyazaki K, Oka K, Ohno T, Kita K, Kobayashi T, Shiku H (2007) Clinicopathologic significance of loss of CD19 expression in diffuse large B-cell lymphoma. Int J Hematol 85:41\u201348","journal-title":"Int J Hematol"},{"key":"2325_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","volume":"3","author":"P Engel","year":"1995","unstructured":"Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF (1995) Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39\u201350","journal-title":"Immunity"},{"key":"2325_CR21","doi-asserted-by":"crossref","first-page":"29588","DOI":"10.1074\/jbc.M102221200","volume":"276","author":"J Lin","year":"2001","unstructured":"Lin J, Weiss A (2001) Identification of minimal tyrosine residues required for linker for activation of T cell function. J Biol Chem 276:29588\u201329595","journal-title":"J Biol Chem"},{"key":"2325_CR22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1042\/bst0320332","volume":"32","author":"K Okkenhaug","year":"2004","unstructured":"Okkenhaug K, Bilancio A, Emery JL, Vanhaesebroek B (2004) Phosphoinositide 3-kinase in T cell activation and survival. Biochem Soc Trans 32:332\u2013335","journal-title":"Biochem Soc Trans"},{"key":"2325_CR23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levin","year":"1997","unstructured":"Levin AJ (1997) P53, the cellular gatekeeper for growth and division. Cell 88:323\u2013331","journal-title":"Cell"},{"key":"2325_CR24","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/j.1460-2075.1995.tb00251.x","volume":"14","author":"ET Stuart","year":"1995","unstructured":"Stuart ET, Haffner R, Oren M, Gruss P (1995) Loss of p53 function through PAX-mediated transcriptional repression. EMBO J 14:5638\u20135645","journal-title":"EMBO J"},{"key":"2325_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1025652203472","volume":"34","author":"M Babjuk","year":"2002","unstructured":"Babjuk M, Soukup V, Mares J, Duskova J, Sedlacek Z, Trkova M, Pecen L, Dvoracek J, Hanus T, Kocvara R, Novak J, Povysil C (2002) The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue: correlation with pathological findings and clinical outcome. Int Urol Nephrol 34:495\u2013501","journal-title":"Int Urol Nephrol"},{"key":"2325_CR26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.urology.2005.10.053","volume":"67","author":"M Babjuk","year":"2006","unstructured":"Babjuk M, Soukup V, Mares J, Duskova J, Pecen L, Pesl M, Pavlik I, DvorRcek J (2006) Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder. Urology 67:756\u2013761","journal-title":"Urology"},{"key":"2325_CR27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12185-010-0691-9","volume":"92","author":"M Proulx","year":"2010","unstructured":"Proulx M, Cayer MP, Drouin M, Laroche A, Jung D (2010) Overexpression of PAX5 induces apoptosis in multiple myeloma cells. Int J Hematol 92:451\u2013462","journal-title":"Int J Hematol"},{"key":"2325_CR28","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/MCB.23.6.2017-2028.2003","volume":"23","author":"D Davidson","year":"2003","unstructured":"Davidson D, Bakinowski M, Thomas ML, Horejsi V, Veillette A (2003) Phosphorylation dependent regulation of T-cell activation by PAG\/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 23:2017\u20132028","journal-title":"Mol Cell Biol"},{"key":"2325_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.pharmtox.39.1.67","volume":"39","author":"TP Dalton","year":"1999","unstructured":"Dalton TP, Shertzer HG, Puga A (1999) Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39:67\u2013101","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2325_CR30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10495-005-0617-9","volume":"10","author":"K Brecht","year":"2005","unstructured":"Brecht K, Simonen M, Brachat A, Heim J (2005) Upregulation of alpha globin promotes apoptotic cell death in the hematopoietic cell line FL5.12. Apoptosis 10:1043\u20131062","journal-title":"Apoptosis"},{"key":"2325_CR31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.cub.2008.10.060","volume":"18","author":"A Vichalkovski","year":"2005","unstructured":"Vichalkovski A, Gresko E, Cornils H, Hergovich A, Schmitz D, Hemmings BA (2005) NDR kinase is activated by RASSF1A\/MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr Biol 18:1889\u20131895","journal-title":"Curr Biol"},{"key":"2325_CR32","doi-asserted-by":"crossref","first-page":"22335","DOI":"10.1074\/jbc.M501631200","volume":"280","author":"BK Koo","year":"2005","unstructured":"Koo BK, Yoon KJ, Yoo KW, Lim HS, Song R, So JH, Kim CH, Kong YY (2005) Mind bomb 2 is an E3 ligase for Notch ligand. J Biol Chem 280:22335\u201322342","journal-title":"J Biol Chem"},{"key":"2325_CR33","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3109\/10428194.2013.867486","volume":"55","author":"PY Huang","year":"2014","unstructured":"Huang PY, Best OG, Almazi JG, Belov L, Davis ZA, Majid A, Dyer MJ, Pascovici D, Mulligan SP, Chrisopherson RI (2014) Cell surface phenotype profiles distinguish stable and progressive chronic lympnocyticleukemia. Leuk Lymphoma 55:2085\u20132092","journal-title":"Leuk Lymphoma"},{"key":"2325_CR34","doi-asserted-by":"crossref","first-page":"e74853","DOI":"10.1371\/journal.pone.0074853","volume":"8","author":"R Lu","year":"2013","unstructured":"Lu R, Jiang M, Chen Z, Xu X, Hu H, Zhao X, Gao X, Guo L (2013) Lactate dehydrogenase 5 expression in non-hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis. PLoS ONE 8:e74853","journal-title":"PLoS ONE"},{"key":"2325_CR35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4236\/ojgen.2013.31004","volume":"3","author":"NJ Weinreb","year":"2013","unstructured":"Weinreb NJ, Rosenbloom BE (2013) Splenomegaly, hypersplenism, and hereditary disorder with splenomegaly. Open J genetics 3:24\u201343","journal-title":"Open J genetics"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-014-2325-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2325-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T10:26:28Z","timestamp":1650968788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-014-2325-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2325"],"URL":"https:\/\/doi.org\/10.1007\/s11010-014-2325-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]}}}